ebook Munafa Stock Market Course + Intraday & FNO calls  

       

NVO announcements Novo Nordisk A/s announcements and dividends declared NYSE

Novo Nordisk A/s Complete list of announcements declared & dividend announcements by Novo Nordisk A/s NVO

Novo Nordisk A/s NVO listed on NYSE and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Novo Nordisk A/s NVO

Novo Nordisk slashes Wegovy prices in India by up to 37% to boost sluggish sales of weight-loss drug
According to renowned endocrinologist Dr Shashank Joshi, a steep cut in the prices of Wegovy will help improve access and affordability. “But it has to be cautioned that weight loss drugs are not cosmetic medicines. It has to be prescribed to the right pat
Announcement as on 11 November 2025

Novo Nordisk partners with Emcure to launch weight-loss drug under new brand in India
Novo Nordisk has partnered with Emcure Pharmaceuticals to bring Poviztra, their latest weight-loss medication, to the Indian market. This collaboration builds on Novo Nordisk's prior success with Wegovy and follows Eli Lilly's competition in this space. Af
Announcement as on 10 November 2025

Novo Nordisk ties up with Emcure to expand reach of weight-loss drug semaglutide in India
Novo Nordisk has partnered with Emcure Pharma to distribute and market its diabetes and weight loss injection semaglutide under the brand name Poviztra in India. This collaboration aims to expand access to the drug by leveraging Emcure's extensive distribu
Announcement as on 10 November 2025

Novo Nordisk’s Wegovy could soon have a new sales outlet in the U.S.

Announcement as on 04 November 2025

Novo Nordisk, Eli Lilly fall after Trump vows to lower weight-loss drug costs

Announcement as on 17 October 2025

Announcements by Novo Nordisk A/s first page | Next page | Prev page |

NVO Novo Nordisk A/s current price & indicator signals

Moving Averages for Novo Nordisk A/s

  • 5Day Average: 46.2
  • 12Day Average: 45.63
  • 20Day Average: 43.53
  • 50Day Average: 40.15
  • 100Day Average: 45.83
  • 150Day Average: 47.17
  • 200Day Average: 49.11

NVO Indicators & signals

Indicator MACD (12,26,9)

45.09, 43.35, 1.67
Indicator MACD is in positive zone

Indicator ADX (14)

17.07, 33.57, 23.78
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 51
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of NVO Novo Nordisk A/s are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
15 Fri May 2026 44.74 44.25 to 45.50 -2.31% 0.94 times
14 Thu May 2026 45.80 45.54 to 46.84 -2.72% 0.76 times
13 Wed May 2026 47.08 46.65 to 47.21 0.17% 0.57 times
12 Tue May 2026 47.00 46.29 to 47.11 1.29% 0.82 times
11 Mon May 2026 46.40 46.27 to 47.79 0.72% 1.03 times
08 Fri May 2026 46.07 45.19 to 46.14 0.59% 0.69 times
07 Thu May 2026 45.80 45.75 to 47.08 0.11% 0.97 times
06 Wed May 2026 45.75 45.53 to 47.55 -0.02% 1.49 times
06 Wed May 2026 45.76 45.53 to 47.55 1.94% 1.78 times
05 Tue May 2026 44.89 44.21 to 45.12 1.13% 1.02 times
04 Mon May 2026 44.39 43.39 to 45.02 1.16% 0.86 times
01 Fri May 2026 43.88 43.10 to 44.04 3.93% 1.51 times

Videos related to: NVO announcements Novo Nordisk A/s announcements and dividends declared NYSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

NVO announcements Novo Nordisk A/s announcements and dividends declared NYSE

 

Back to top